Metabolomics signature as a survival predictor in patients with resectable colorectal liver metastasis.

Autor: González-Olmedo C; Medical Oncology Unit, University Hospital of Jaén, Jaén, Spain.; Fundación Pública Andaluza para la Investigación Biosanitaria de Andalucía Oriental Alejandro Otero, University Hospital of Jaén, Jaén, Spain.; Department of Biomedicine, Translational Research and Personalised Medicine, University of Granada, Granada, Spain., García-Verdejo FJ; Medical Oncology Unit, University Hospital of Jaén, Jaén, Spain., Reguera-Teba A; Department of General Surgery, University Hospital of Jaén, Jaén, Andalucia, Spain.; Department of Medicine, Faculty of Health Sciences, University of Jaén, Jaén, Spain., Rosa-Garrido C; Fundación Pública Andaluza para la Investigación Biosanitaria de Andalucía Oriental Alejandro Otero, University Hospital of Jaén, Jaén, Spain., López-López JA; Medical Oncology Unit, University Hospital of Jaén, Jaén, Spain., Díaz-Beltrán L; Medical Oncology Unit, University Hospital of Jaén, Jaén, Spain.; Fundación Pública Andaluza para la Investigación Biosanitaria de Andalucía Oriental Alejandro Otero, University Hospital of Jaén, Jaén, Spain., García PM; Fundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Armilla, Granada, Spain., Luque-Caro N; Medical Oncology Unit, University Hospital of Jaén, Jaén, Spain., Gálvez-Montosa F; Medical Oncology Unit, University Hospital of Jaén, Jaén, Spain., Ortega-Granados AL; Medical Oncology Unit, University Hospital of Jaén, Jaén, Spain., Ruiz-Sanjuan M; Medical Oncology Unit, University Hospital of Jaén, Jaén, Spain.; Fundación Pública Andaluza para la Investigación Biosanitaria de Andalucía Oriental Alejandro Otero, University Hospital of Jaén, Jaén, Spain., Cózar-Ibáñez A; Department of General Surgery, University Hospital of Jaén, Jaén, Andalucia, Spain., Sainz J; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, PTS, Granada, Spain.; Instituto de Investigación Biosanataria IBs.Granada, Granada, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health, Barcelona, Spain.; Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain., Marchal JA; Instituto de Investigación Biosanataria IBs.Granada, Granada, Spain.; Biopathology and Regenerative Medicine Institute, Centre for Biomedical Research, University of Granada, Granada, Spain.; Department of Human Anatomy and Embryology, Faculty of Medicine, University of Granada, Granada, Spain.; Excellence Research Unit 'Modeling Nature' (MNat), University of Granada, Granada, Spain., Camacho J; Excellence Research Unit 'Modeling Nature' (MNat), University of Granada, Granada, Spain.; Department of Signal Theory, Networking and Communications, University of Granada, Granada, Spain., Del Palacio JP; Fundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Armilla, Granada, Spain., Fernández-Godino R; Fundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Armilla, Granada, Spain., Díaz C; Fundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Armilla, Granada, Spain., Sánchez-Rovira P; Medical Oncology Unit, University Hospital of Jaén, Jaén, Spain.

Publikováno v: Clinical and translational medicine [Clin Transl Med] 2024 Jan; Vol. 14 (1), pp. e1541.

153P Descriptive analysis of the location of point mutations in BRCA and the risk of breast or ovarian cancer diagnosis

Autor: Torres-Mozas, P., Galvez Montosa, F., Luque Caro, N., Verdejo, F.J.G., Ortega Granados, A.L.O., Requena Aguilar, J., Benoit Perejón, J.Z., Garcia Munoz, R., Vinueza Hidalgo, G.P., Fernández Ros, I., Sanchez-Rovira, P.

Publikováno v: In Annals of Oncology October 2023 34 Supplement 2:S242-S242

427P Real world data of trifluridine/tipiracil in refractory mCRC: A multicenter experience at four GEODA Spanish hospitals

Autor: Martinez Perez, J., Espinosa Montaño, M., Luque Caro, N., Aviñó Tarazona, V.

Publikováno v: In Annals of Oncology September 2021 32 Supplement 5:S548-S548

P-116 What have we learned about of trifluridine/tipiracil (TAS-102)? Real World Data at four GEODA hospitals (Spain)

Autor: Martínez Pérez, J., Espinosa Montaño, M., Luque Caro, N., Aviñó Tarazona, V.

Publikováno v: In Annals of Oncology July 2021 32 Supplement 3:S138-S138

Discovery of Plasma Lipids as Potential Biomarkers Distinguishing Breast Cancer Patients from Healthy Controls.

Autor: Li, Desmond¹ (AUTHOR), Heffernan, Kerry¹ (AUTHOR), Koch, Forrest C.² (AUTHOR), Peake, David A.¹ (AUTHOR), Pascovici, Dana³ (AUTHOR), David, Mark¹ (AUTHOR), Kehelpannala, Cheka¹ (AUTHOR), Mann, G. Bruce⁴ (AUTHOR), Speakman, David^5,6 (AUTHOR), Hurrell, John¹ (AUTHOR), Preston, Simon¹ (AUTHOR) spreston@bcaldiagnostics.com, Vafaee, Fatemeh^2,7 (AUTHOR), Batarseh, Amani¹ (AUTHOR)

Publikováno v: International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 21, p11559. 19p.